Alcon Inc
Research Alcon Inc (ALC) on Bullrun: valuation model: 1.8% undervalued, market cap USD 30.99B, P/E 49.2, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALC
- ExchangeNYSE
- CountrySwitzerland
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal1.8% undervalued
- Market capUSD 30.99B
- P/E49.2
- Dividend yield0.6%
- Financial periodQ2 2026
- RevenueUSD 2.82B
- Net incomeUSD 0
- Free cash flowUSD 370.00M
- Gross margin59.3%
Valuation Snapshot
Bullrun's latest valuation model marks Alcon Inc as 1.8% undervalued; latest market cap is USD 30.99B; P/E is 49.2; dividend yield is 0.6%.
Peer valuation comparison
Latest P/E is 49.16x versus a Healthcare sector median of 24.61x (99.8% above).
Latest dividend yield is 0.56% versus a Healthcare sector median of 1.84% (69.6% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 10.40B | USD 980.00M | USD 1.61B | 55.2% | 1.98 | USD 1.50B | USD 509.00M | USD 22.01B |
| FY2024 | USD 9.91B | USD 1.02B | USD 1.41B | 55.6% | 2.05 | USD 1.68B | USD 497.00M | USD 21.53B |
| FY2023 | USD 9.46B | USD 974.00M | USD 537.00M | 55.5% | 1.96 | USD 1.09B | USD 5.14B | USD 20.62B |
| FY2022 | USD 8.72B | USD 335.00M | USD 472.00M | 54.5% | 0.68 | USD 980.00M | USD 5.07B | USD 19.68B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 30.99B | 49.2 | 0.6% | 0.36 |
| 2025 | 2025-12-31 | USD 38.41B | 40.0 | n/a | n/a |
| 2024 | 2024-12-31 | USD 41.99B | 41.4 | 0.3% | 0.26 |
| 2023 | 2023-12-29 | USD 38.42B | 85.8 | 0.3% | 0.24 |
| 2022 | 2022-12-30 | USD 33.71B | 59.1 | 0.3% | 0.21 |
| 2021 | 2021-12-31 | USD 42.70B | 114.6 | 0.1% | 0.11 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.36 USD, yield 0.6%.
| Year | Dividends/share |
|---|---|
| FY2024 | 0.26 USD |
| FY2023 | 0.24 USD |
| FY2022 | 0.21 USD |
About Alcon Inc
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.
ETFs that hold Alcon Inc
Alcon Inc is one of the ten largest holdings of 2 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| Lloyd International Equity UCITS ETF EUR Acc | 3.99% | 0.85% |
| Swisscanto (CH) ESGen SDG Index Equity Switzerland ETF EA CHF | 4.30% | 0.35% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Alcon Inc overvalued or undervalued?
Bullrun's valuation model currently marks Alcon Inc as 1.8% undervalued.
What is Alcon Inc's market cap?
Alcon Inc's market capitalization is USD 30.99B.
What is Alcon Inc's P/E ratio?
Alcon Inc's price-to-earnings (P/E) ratio is 49.2.
Does Alcon Inc pay a dividend?
Alcon Inc has a dividend yield of 0.6%.
What does Alcon Inc do?
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.